lobbying_activities: 3490114

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3490114	3e3115b4-c01e-4af1-be13-e99d752844b8	Q4	DLA PIPER LLP (US)	76855	AVALYN PHARMA INC.	2025	fourth_quarter	MED	Issues related to lung disease and rare disease.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2026-01-16T15:09:39-05:00